Association of Coloproctology of Great Britain &amp; Ireland (<scp>ACPGBI</scp>): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Follow Up, Lifestyle and Survivorship

Leong, Kai; Hartley, John E.; Karandikar, Sharad

doi:10.1111/codi.13706

Cited by 28 publications

(56 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Considerations regarding the patients who should undergo structured follow‐up were mentioned in 12 guidelines (57%) . All of these guidelines stated that follow‐up should only be offered to patients who are able to receive further treatment if recurrence is detected.…”

Section: Resultsmentioning

confidence: 99%

“…The intensity of the follow‐up programme was mentioned in 16 guidelines (76%) . Four of these recommended intensive follow‐up, but a uniform definition of intensive follow‐up was lacking.…”

Section: Resultsmentioning

confidence: 99%

“…The role of carcinoembryonic antigen (CEA) during the follow‐up of CRC patients was discussed in 20 guidelines (95%) . The Danish and SIGN guidelines state that more evidence on the role of CEA is required and, therefore, routine estimation of CEA is not recommended.…”

Section: Resultsmentioning

confidence: 99%

“…The role of chest imaging during follow‐up of CRC patients was mentioned in all guidelines. Nineteen guidelines recommend that chest imaging should be routinely performed. The German and EURECCA guidelines stated that only rectal cancer patients should undergo routine chest imaging.…”

Section: Resultsmentioning

confidence: 99%

“…In 16 guidelines (84%) , it was recommended to use CT, whether or not alternating with X‐ray, for the detection of lung metastases. In the German , Hungarian and Russian guidelines, radiography was the preferred modality.…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology

et al. 2019

View full text Add to dashboard Cite

Aim It is common clinical practice to follow patients for a period of years after treatment with curative intent of nonmetastatic colorectal cancer, but follow‐up strategies vary widely. The aim of this systematic review was to provide an overview of recommendations on this topic in guidelines from member countries of the European Society of Coloproctology, with supporting evidence. Method A systematic search of Medline, Embase and the guideline databases Trip database, BMJ Best Practice and Guidelines International Network was performed. Quality assessment included use of the AGREE‐II tool. All topics with recommendations from included guidelines were identified and categorized. For each subtopic, a conclusion was made followed by the degree of consensus and the highest level of evidence. Results Twenty‐one guidelines were included. The majority recommended that structured follow‐up should be offered, except for patients in whom treatment of recurrence would be inappropriate. It was generally agreed that clinical visits, measurement of carcinoembryoinc antigen and liver imaging should be part of follow‐up, based on a high level of evidence, although the frequency is controversial. There was also consensus on imaging of the chest and pelvis in rectal cancer, as well as endoscopy, based on lower levels of evidence and with a level of intensity that was contradictory. Conclusion In available guidelines, multimodal follow‐up after treatment with curative intent of colorectal cancer is widely recommended, but the exact content and intensity are highly controversial. International agreement on the optimal follow‐up schedule is unlikely to be achieved on current evidence, and further research should refocus on individualized ‘patient‐driven’ follow‐up and new biomarkers.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology

et al. 2019

View full text Add to dashboard Cite

show abstract

Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer

Snyder

Cuddy

et al. 2018

JAMA

View full text Add to dashboard Cite

show abstract

Body Composition, Inflammation, and 5-Year Outcomes in Colon Cancer

et al. 2021

View full text Add to dashboard Cite

IMPORTANCE Obesity, particularly visceral obesity and sarcopenia, are poor prognostic indicators in colon cancer. OBJECTIVES To explore the association between body composition profiles and 5-year colon cancer outcomes and delineate the associated underlying inflammatory processes. DESIGN, SETTING, AND PARTICIPANTS This multicenter translational cohort study included patients with nonmetastatic colon cancer who did not have underlying chronic inflammatory disorders and were not receiving anti-inflammatory drugs referred to tertiary cancer centers from 2009 to 2015. Preoperative acute phase proteins (white cell count, C-reactive protein, and albumin), cytokines (interleukin [IL]-1b, IL-2, IL-6, IL-10, interferon γ, and tumor necrosis factor α), vascular endothelial growth factor (VEGF), and cell surface receptor expression levels (CD11b and CD14) were measured. All patients underwent follow-up for at least 5 years. Data were analyzed in December 2020. EXPOSURE Nonmetastatic colon cancer. MAIN OUTCOMES AND MEASURES The associations of body composition profiles with 5-year cancer recurrence and disease-specific mortality were analyzed using Mantel Cox log-rank test and Kaplan-Meier curves. RESULTS A total of 28 patients were included (median [interquartile range] age, 67 [58-72] years;22 [78.6%] men). Low skeletal muscle area (SMA) and high visceral to total fat ratio were associated with poor clinical and oncological outcomes, including increased 5-year recurrence (low SMA: hazard ratio [HR], 2.30 [95% CI, 1.41-2.89]; P = .04; high visceral to total fat ratio: HR, 5.78 [95% CI, 3.66-7.95]; P = .02). High visceral to total fat ratio was associated with increased 5-year disease-specific mortality (HR,5.

show abstract

Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Follow Up, Lifestyle and Survivorship

Cited by 28 publications

References 19 publications

Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology

Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology

Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer

Body Composition, Inflammation, and 5-Year Outcomes in Colon Cancer

Contact Info

Product

Resources

About